Returned drugs headache for wholesalers

Drug wholesalers have found it increasingly difficult to deal with expired medicine stocks as well as product license-retracted ones due to the controversial bioequivalence data fabrication.

Pharmaceutical business sources said drug wholesalers just wait for decisions from pharmaceutical companies for the returned goods.

Many wholesalers say the problem of returned gooos has surfaced sinc...